Cortexyme

Feb 25, 2025

Alzheimer’s Disease: Navigating the Rising Incidence, Evolving Treatments, and Market Dynamics

Feb 18, 2021

Bluebird suspends gene therapy trials; Cortexyme tripped up by FDA hold; Guardant Health launches surveillance blood test; Enhertu scores approval

Newsletter/Whitepaper